Genfo Bioceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 25-07-2024
- Paid Up Capital ₹ 1.50 M
as on 25-07-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 35.00 M
as on 25-07-2024
- Revenue 6.84%
(FY 2023)
- Profit 11.47%
(FY 2023)
- Ebitda 48.79%
(FY 2023)
- Net Worth 18.40%
(FY 2023)
- Total Assets 61.97%
(FY 2023)
About Genfo Bioceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.50 Cr.
Neeraja Ganta and Rajeshwasr Ganta serve as directors at the Company.
- CIN/LLPIN
U51909TG2013PTC089846
- Company No.
089846
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Uppal, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Genfo Bioceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraja Ganta  | Director | 04-Sep-2013 | Current |
| Rajeshwasr Ganta | Director | 04-Sep-2013 | Current |
Financial Performance and Corporate Structure Insights of Genfo Bioceuticals.
Genfo Bioceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.84% increase. The company also saw a substantial improvement in profitability, with a 11.47% increase in profit. The company's net worth Soared by an impressive increase of 18.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genfo Bioceuticals?
In 2023, Genfo Bioceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 20 Nov 2014 | ₹3.50 Cr | Open |
How Many Employees Work at Genfo Bioceuticals?
Genfo Bioceuticals has a workforce of 33 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genfo Bioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genfo Bioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
